Shareholder Bai Ying of Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) plans to reduce their holdings by no more than 1.5%.

Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SH) announced that shareholder Bai Ying, who holds 5.63% of the company's shares, plans to reduce their holdings by no more than 2.8432 million shares through block trades, or a reduction of no more than 1.5% of the company's total share capital. The reduction plan will be implemented within 3 months after 15 trading days from the announcement date (December 10, 2024 to March 9, 2025).